Stocktoria
Cocrystal Pharma, Inc. COCP
Cocrystal Pharma, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $2.0M | $6.6M | — | — | — |
| R&D expense | $5.1M | $12.5M | $15.2M | $12.4M | $8.8M | $6.0M | $4.0M | $4.7M | $5.8M | $101.7M |
| Operating income | -$9.0M | -$17.9M | -$18.6M | -$38.8M | -$14.2M | -$9.6M | -$48.4M | -$62.9M | -$8.3M | -$105.8M |
| Interest expense | — | — | -$640,000 | $2,000 | $4,000 | $8,000 | $19,000 | $58,000 | — | — |
| Income tax | — | — | — | — | — | — | — | -$13.6M | -$6.9M | -$29.4M |
| Net income | -$8.8M | -$17.5M | -$18.0M | -$38.8M | -$14.2M | -$9.6M | -$48.2M | -$49.0M | -$613,000 | -$74.9M |
| EPS (diluted) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | — | — | — | — | $-0.03 | $-3.30 |
| Operating cash flow | -$8.2M | -$16.5M | -$14.7M | -$21.4M | -$12.7M | -$9.8M | -$1.6M | -$8.3M | -$6.9M | -$14.7M |
| Free cash flow | -$8.2M | -$16.5M | -$14.8M | -$21.5M | -$12.8M | -$10.1M | -$1.7M | -$8.3M | -$6.9M | -$14.7M |
| Cash & equivalents | $7.0M | $9.9M | $26.4M | $37.1M | $58.7M | $33.0M | $7.4M | — | $748,000 | $3.6M |
| Total assets | $9.7M | $13.5M | $31.3M | $40.8M | $79.4M | $54.2M | $28.5M | $68.6M | $121.4M | $124.9M |
| Total liabilities | $3.4M | $3.9M | $4.9M | $1.3M | $1.8M | $1.7M | $2.8M | $1.7M | $16.0M | $22.6M |
| Shareholders' equity | $6.3M | $9.5M | $26.4M | $39.6M | $77.5M | $52.5M | $25.7M | $66.9M | $105.4M | $102.3M |
Growth · year-over-year · Revenue CAGR -69.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | — | -69.3% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.